The Study - The Use of Cannabidiol-Rich Hemp Oil Extract to Treat Canine Osteoarthritic-Related Pain
In 2018 we participated in a veterinary clinical trial study aimed at understanding “The Use of Cannabidiol-Rich Hemp Oil Extract to Treat Canine Osteoarthritis-Related Pain”. More simply, that means that the goal of this study was to understand if hemp-infused full-spectrum hemp oil is truly effective at relieving canine osteoarthritic pain. As our mission behind HempMy Pet™ is to improve pet’s quality of life, we were excited at the idea of participating in a study with some of the top veterinary researchers in the field.
What the Study Showed
In this 90-day trial, 37 dogs were enrolled. Due to varying reasons, 32 of the dogs completed the full 90 days. Of those 32 dogs, 30 dogs demonstrated improved pain support. This was measured by an initial physical examination that included a pain and tenderness exam, mapping of the pain patterns, an informal gait analysis, metabolic profile, and interview with each dog’s owner. The same exams and mappings were performed during biweekly assessment to inform dose adjustments while the metabolic parameters were repeated at the end of the study.
Throughout the study, each dog’s amount of CBD was closely monitored as the gabapentin was reduced. Additionally, of the 23 dogs in the study that were taking gabapentin (a prescription that helps with pain and seizures), 10 were able to discontinue use entirely and 11 others were able to decrease their dosage with the addition of our hemp-infused hemp seed oil. This ensured each dog’s quality of comfort was retained as their amounts were adjusted.
In order to remove any unnecessary variables, all participants continued to stay on all prescription medications to prevent a withdrawal pain response. This applied to dogs on gabapentin, polysulfated glycosaminoglycan, and those receiving medical acupuncture. However, new prescriptions or medical modalities were not allowed during the course of this study. If a dog needed further care based on pre-existing conditions, they removed themselves from the study as needed.
1. Benefits after the 90-day trial included decreased pain scores, improvements in mobility, and improved quality of life as defined by their owners in 93% of participants.
2. 23 dogs in the study were taking gabapentin for their pain. Out of the 23, 10 dogs were able to discontinue gabapentin with the addition of CBD oil. Of the 13 dogs who continued to take gabapentin, 11 dogs were able to reduce their dose to 20% to 60% of the original dose. This suggests that a CBD product, at an appropriate therapeutic dose, may provide a gabapentin-sparing effect for dogs experiencing chronic maladaptive pain.
3. Due to the variation from product to product of CBD content and constituents such as terpenes, cannabinoids, and flavonoids, it is essential to publish an analysis of the product being tested in order to describe that specific cultivar. HempMy Pet™ grows one specific cultivar (or strain) of hemp for our extract, every time, for all of our products. Consistency is just as important as quality when it comes to your CBD products.
Thank you, Dr. Robin Downing, world-renowned pain specialist in veterinary medicine and Hospital Director of the Downing Center for Animal Pain Management in Windsor, CO, and researchers Dr. Lori Kogan and Dr. Peter Hellyer from the from the College of Veterinary Medicine and Biomedical Sciences at Colorado State University.
Read the peer-reviewed study as published in 2020 in the Journal of the American Holistic Veterinary Medical Association (AHVMA) in its entirety here.